Patents by Inventor Nathan Aaron EDWARDS

Nathan Aaron EDWARDS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250042984
    Abstract: The present disclosure is directed to a liquid formulation comprising high concentration of a protein comprising an antigen binding domain that binds to VEGF-B, an organic buffer, a non-ionic surfactant and an amino acid stabilizer, wherein the pH of the formulation is 5.0-6.5. The formulation comprises a histidine buffer, a polysorbate 80 surfactant and the amino acid stabilizers arginine and proline.
    Type: Application
    Filed: December 19, 2022
    Publication date: February 6, 2025
    Applicant: CSL Innovation Pty Ltd
    Inventors: Mouhamad RESLAN, Nathan Aaron EDWARDS, Megan GARVEY, Daniel LA PORTA
  • Publication number: 20240277839
    Abstract: The present disclosure relates to high concentration protein formulations and uses thereof. In particular, it is based on the identification of a pharmaceutical formulation for a protein comprising an antigen binding domain that binds to or specifically binds to Factor XII and/or FXIIa.
    Type: Application
    Filed: July 5, 2021
    Publication date: August 22, 2024
    Inventors: Michael JOHNSTON, Dianna Grace GOODALL, Nathan Aaron EDWARDS
  • Publication number: 20240002517
    Abstract: The present disclosure relates to protein formulations and uses thereof. In particular, the present disclosure relates to formulations comprising a protein comprising an antigen binding domain that binds to or specifically binds to granulocyte colony-stimulating factor receptor (G-CSFR).
    Type: Application
    Filed: July 9, 2021
    Publication date: January 4, 2024
    Inventors: Dianna Grace GOODALL, Nathan Aaron EDWARDS, Gemma NASSTA, Mouhamad RESLAN